advertisement

Topcon

Clinical and Experimental Ophthalmology 11

Showing records 1 to 11 | Display all abstracts in Clinical and Experimental Ophthalmology

59302 Cataract and quality of life in patients with glaucoma
Skalicky SE; Martin KR; Fenwick E; Crowston JG; Goldberg I; McCluskey P
Clinical and Experimental Ophthalmology 2015; 43: 335-341
59449 Clinical model assisting with the collaborative care of glaucoma patients and suspects
Jamous KF; Kalloniatis M; Hennessy MP; Agar A; Hayen A; Zangerl B
Clinical and Experimental Ophthalmology 2015; 43: 308-319
58844 Cambridge community Optometry Glaucoma Scheme
Keenan J; Shahid H; Bourne RR; White AJ; Martin KR
Clinical and Experimental Ophthalmology 2015; 43: 221-227
58885 Identification of novel CYP1B1 gene mutations in patients with primary congenital and primary open-angle glaucoma
Micheal S; Ayub H; Zafar SN; Bakker B; Ali M; Akhtar F; Islam F; Khan MI; Qamar R; den Hollander AI
Clinical and Experimental Ophthalmology 2015; 43: 31-39
58735 Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension
Razali N; Agarwal R; Agarwal P; Kumar S; Tripathy M; Vasudevan S; Crowston JG; Ismail NM
Clinical and Experimental Ophthalmology 2015; 43: 54-66
58958 Twenty-four-hour intraocular pressure patterns in patients with thyroid eye disease
Parekh AS; Mansouri K; Weinreb RN; Tafreshi A; Korn BS; Kikkawa DO
Clinical and Experimental Ophthalmology 2015; 43: 108-114
59118 Reproducibility of the water drinking test in treated glaucomatous patients
Babic M; De Moraes CG; Hatanaka M; Ju G; Susanna R
Clinical and Experimental Ophthalmology 2015; 43: 228-233
59117 Severe intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit
Fitzgerald JT; Saunders L; Ridge B; White AJ; Goldberg I; Clark B; Mills RA; Craig JE
Clinical and Experimental Ophthalmology 2015; 43: 234-238
58788 Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line and the protective role of preservative-free tafluprost
Chang C; Zhang AQ; Kagan DB; Liu H; Hutnik CM
Clinical and Experimental Ophthalmology 2015; 43: 164-172
59068 Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease
Goldberg I; Graham SL; Crowston JG; d'Mellow G;
Clinical and Experimental Ophthalmology 2015; 43: 214-220
59297 Intraocular pressure-lowering medications and long-term outcomes of selective laser trabeculoplasty
Woo DM; Healey PR; Graham SL; Goldberg I
Clinical and Experimental Ophthalmology 2015; 43: 320-327

Issue 16-3

Change Issue


advertisement

Oculus